Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Development Agreement - MSC Shipmanagement

21 Jan 2021 07:00

RNS Number : 3888M
Quadrise Fuels International PLC
21 January 2021
 

21 January 2021

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

 

JOINT DEVELOPMENT AGREEMENT WITH MSC SHIPMANAGEMENT LIMITED

 

Quadrise is pleased to announce it has signed a Joint Development Agreement ("JDA") with MSC Shipmanagement Limited of Cyprus ("MSC"), a 100% subsidiary of MSC Mediterranean Shipping Company SA headquartered in Geneva, to carry out an MSAR® Operational Trial (the "Trial") on commercial container vessels in the MSC global fleet commencing in 2021 with, subject to further agreement, subsequent commercial rollout upon success. The MSC Group is one of the world's largest cargo shipping and cruise line companies.

 

Initial activities under the JDA will include project initiation, definition, high-level scoping and feasibility activities ("Initial Activities") of the overall Trial. The Initial Activities are to be completed within 3 months.

 

Contingent on the outcome of the Initial Activities the parties will progress and define the project roadmap during Q2'21 in preparation for the execution of one or more Trials commencing in H2'21 on representative commercial vessels in MSC's global fleet ("Phase 1"). Upon completion and success of Phase 1, and subject to further agreement between the parties, the JDA envisages subsequent commercial roll-out across the MSC global fleet ("Phase 2").

 

Phase 1 will see the testing of MSAR® fuel in a large MAN ME and/or a Wärtsilä/WinGD Flex 2-stroke engine so as to obtain Letter Of No Objection ("LONO") approvals from the respective engine manufacturers. Phase 1 testing may also incorporate testing of QFI's new bioMSARTM biofuel.

 

In the event that the Trial(s) and LONO approval(s) are successful under Phase 1, and subject to further commercial agreements to be agreed between the parties, the parties would seek to rollout MSAR® fuel, and potentially bioMSARTM, for the MSC global fleet.

 

The JDA will capitalise on QFI's skills in emulsion fuel application and use in large diesel engines. MSC will contribute its vast shipping industry experience and provide technical expertise relating to naval architecture, machinery systems, fuels, exhaust gas cleaning systems, emissions and technical ship management. MSC is at the forefront of exploring and trialling fuels and technologies to help decarbonise the international shipping industry.

Commenting on this agreement Jason Miles, CEO of QFI, said:

"Quadrise is delighted to have signed this agreement with MSC and we look forward to working alongside them to progress this excellent opportunity. We believe that MSC's large modern fleet installed with electronic engines and, in some cases, exhaust gas cleaning systems (scrubbers) is well positioned to realise the economic and environmental benefits of MSAR® and bioMSARTM and we look forward to realising the project and getting the trials underway in 2021."

Commenting on this agreement Prabhat Jha, Group MD & CEO of MSC Shipmanagement Ltd, said:

"MSC is looking forward to working with the Quadrise team under the JDA in 2021 to scope out the operational trials of MSAR® on our container vessels. We are particularly interested in the potential environmental benefits of MSAR® and bioMSARTM that, alongside the economic benefits, reflect our approach to operating a modern MSC fleet, and fit well with our overall future fuels strategy."

 

 

For further information, please contact:

 

Quadrise Fuels International Plc

 

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

 

 

Nominated Adviser

 

Cenkos Securities plc

 

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

 

 

Joint Brokers

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

David McKeown

 

 

 

Shore Capital Stockbrokers Limited

 

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAAFEAFFFEAA
Date   Source Headline
4th Dec 200712:16 pmRNSGrant of Options
3rd Dec 20074:40 pmRNSDirectorate Change
8th Oct 20077:01 amRNSFinal Results
17th Aug 20072:47 pmRNSAIM Notice (Rule 26)
17th Jul 20077:01 amRNSUpdate on Plans
6th Jul 20074:31 pmRNSDirector/PDMR Shareholding
19th Jun 200711:44 amRNSEquity Stake
26th Apr 200711:36 amRNSAnnual General Meeting
21st Mar 200712:00 pmRNSInterim Results
7th Mar 20072:33 pmRNSNotice of Results
26th Jan 20077:01 amRNSUpdate on Activities
9th Jan 20072:14 pmRNSDirector/PDMR Shareholding
18th Dec 200611:15 amRNSTotal Voting Rights
24th Nov 20062:37 pmRNSIssue of Equity
15th Nov 20064:34 pmRNSDirector/PDMR Shareholding
14th Nov 20064:33 pmRNSDirector/PDMR Shareholding
13th Nov 200611:21 amRNSDirector/PDMR Shareholding
10th Nov 200610:38 amRNSDirector/PDMR Shareholding
6th Nov 20064:18 pmRNSIssue of Equity
2nd Nov 200611:36 amRNSDirector/PDMR Shareholding
5th Oct 200610:27 amRNSStatement re Orimulsion
21st Sep 20064:29 pmRNSUpdate on Activities
17th Jul 20064:16 pmRNSChange in year end
19th Jun 200610:32 amRNSDirector/PDMR Shareholding
31st May 20067:02 amRNSFinal Results
19th Apr 200611:56 amRNSAdmission to AIM
18th Apr 20063:25 pmRNSEGM Statement
24th Mar 20069:58 amRNSSch 1 - Quadrise Fuels Intl
23rd Mar 20067:01 amRNSInterim Results
23rd Mar 20067:01 amRNSRestoration - Zareba PLC
23rd Mar 20067:00 amRNSAcquisition
17th Mar 200612:39 pmRNSLetter to Shareholders
3rd Jan 20063:58 pmRNSDirectorate Change
12th Dec 20055:18 pmRNSStatement re. Suspension
12th Dec 20055:17 pmRNSRelated Party Transaction
12th Dec 20052:15 pmRNSSuspension - Zareba PLC
9th Dec 20057:01 amRNSChange of Adviser
18th Oct 200511:03 amRNSDirector/PDMR Shareholding
30th Sep 20054:22 pmRNSInterim Results
8th Jun 20057:00 amRNSAcquisition
14th Mar 200511:46 amRNSIssue of Equity
25th Feb 20052:35 pmRNSHolding(s) in Company
21st Feb 20055:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.